BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,839,000 | -46.7% | 5,790,000 | -50.0% | 0.54% | -34.0% |
| Q1 2018 | $12,823,000 | -54.4% | 11,585,000 | -51.1% | 0.83% | -50.2% |
| Q4 2017 | $28,126,000 | +4.8% | 23,685,000 | +6.2% | 1.66% | +20.7% |
| Q3 2017 | $26,844,000 | +17560.5% | 22,300,000 | +17740.0% | 1.37% | +22800.0% |
| Q4 2014 | $152,000 | +10.9% | 125,000 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $137,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |